Denali Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,600
| Closed | -$139K | – | 471 |
|
|
2024
Q1 | $139K | Hold |
26,600
| – | – | 0.04% | 255 |
|
|
2023
Q4 | $139K | Sell |
26,600
-5,700
| -18% | -$29.8K | 0.04% | 256 |
|
|
2023
Q3 | $509K | Buy |
32,300
+11,100
| +52% | +$175K | 0.18% | 138 |
|
|
2023
Q2 | $412K | Buy |
21,200
+19,200
| +960% | +$373K | 0.14% | 157 |
|
|
2023
Q1 | $56.7K | Hold |
2,000
| – | – | 0.02% | 213 |
|
|
2022
Q4 | $58.5K | Buy |
+2,000
| New | +$58.5K | 0.02% | 207 |
|